vs

Side-by-side financial comparison of MultiSensor AI Holdings, Inc. (MSAI) and TScan Therapeutics, Inc. (TCRX). Click either name above to swap in a different company.

TScan Therapeutics, Inc. is the larger business by last-quarter revenue ($2.6M vs $1.4M, roughly 1.8× MultiSensor AI Holdings, Inc.). MultiSensor AI Holdings, Inc. runs the higher net margin — -164.1% vs -895.1%, a 731.0% gap on every dollar of revenue. On growth, TScan Therapeutics, Inc. posted the faster year-over-year revenue change (286.0% vs -0.9%). MultiSensor AI Holdings, Inc. produced more free cash flow last quarter ($-2.6M vs $-32.2M). Over the past eight quarters, TScan Therapeutics, Inc.'s revenue compounded faster (-9.7% CAGR vs -21.9%).

Figure AI, Inc. is an American robotics company developing AI-powered humanoid robots. The company was founded in 2022 by Brett Adcock, also known for founding Archer Aviation and Vettery.

TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel T cell receptor (TCR) immunotherapies for hard-to-treat cancers. Its proprietary platform identifies high-affinity naturally occurring TCRs targeting tumor antigens, with pipeline candidates spanning hematological malignancies and solid tumors, operating in the global oncology therapeutics market.

MSAI vs TCRX — Head-to-Head

Bigger by revenue
TCRX
TCRX
1.8× larger
TCRX
$2.6M
$1.4M
MSAI
Growing faster (revenue YoY)
TCRX
TCRX
+286.9% gap
TCRX
286.0%
-0.9%
MSAI
Higher net margin
MSAI
MSAI
731.0% more per $
MSAI
-164.1%
-895.1%
TCRX
More free cash flow
MSAI
MSAI
$29.6M more FCF
MSAI
$-2.6M
$-32.2M
TCRX
Faster 2-yr revenue CAGR
TCRX
TCRX
Annualised
TCRX
-9.7%
-21.9%
MSAI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MSAI
MSAI
TCRX
TCRX
Revenue
$1.4M
$2.6M
Net Profit
$-2.3M
$-23.0M
Gross Margin
Operating Margin
-171.6%
-929.4%
Net Margin
-164.1%
-895.1%
Revenue YoY
-0.9%
286.0%
Net Profit YoY
23.7%
35.8%
EPS (diluted)
$-0.02
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSAI
MSAI
TCRX
TCRX
Q4 25
$1.4M
$2.6M
Q3 25
$1.6M
$2.5M
Q2 25
$1.4M
$3.1M
Q1 25
$1.2M
$2.2M
Q4 24
$1.4M
Q3 24
$1.6M
$1.0M
Q2 24
$2.1M
Q1 24
$2.3M
Net Profit
MSAI
MSAI
TCRX
TCRX
Q4 25
$-2.3M
$-23.0M
Q3 25
$-1.7M
$-35.7M
Q2 25
$-3.3M
$-37.0M
Q1 25
$-4.4M
$-34.1M
Q4 24
$-3.0M
Q3 24
$-8.2M
$-29.9M
Q2 24
$-6.4M
Q1 24
$-3.9M
Operating Margin
MSAI
MSAI
TCRX
TCRX
Q4 25
-171.6%
-929.4%
Q3 25
-107.6%
-1475.6%
Q2 25
-233.8%
-1256.6%
Q1 25
-394.6%
-1669.7%
Q4 24
-199.6%
Q3 24
-541.5%
-3109.8%
Q2 24
-228.1%
Q1 24
-112.7%
Net Margin
MSAI
MSAI
TCRX
TCRX
Q4 25
-164.1%
-895.1%
Q3 25
-106.5%
-1422.1%
Q2 25
-234.1%
-1201.3%
Q1 25
-379.1%
-1571.9%
Q4 24
-213.2%
Q3 24
-511.5%
-2849.1%
Q2 24
-300.8%
Q1 24
-172.4%
EPS (diluted)
MSAI
MSAI
TCRX
TCRX
Q4 25
$-0.02
$-0.18
Q3 25
$-0.05
$-0.28
Q2 25
$-0.10
$-0.28
Q1 25
$-0.14
$-0.26
Q4 24
$0.07
Q3 24
$-0.34
$-0.25
Q2 24
$-0.47
Q1 24
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSAI
MSAI
TCRX
TCRX
Cash + ST InvestmentsLiquidity on hand
$24.4M
$152.4M
Total DebtLower is stronger
$32.5M
Stockholders' EquityBook value
$32.0M
$123.1M
Total Assets
$35.5M
$228.8M
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSAI
MSAI
TCRX
TCRX
Q4 25
$24.4M
$152.4M
Q3 25
$1.1M
$184.5M
Q2 25
$3.2M
$218.0M
Q1 25
$4.7M
$251.7M
Q4 24
$4.4M
Q3 24
$8.6M
$271.1M
Q2 24
$234.0K
Q1 24
$491.0K
Total Debt
MSAI
MSAI
TCRX
TCRX
Q4 25
$32.5M
Q3 25
$32.4M
Q2 25
$32.3M
Q1 25
$32.2M
Q4 24
Q3 24
$30.6M
Q2 24
$642.0K
Q1 24
$2.8M
Stockholders' Equity
MSAI
MSAI
TCRX
TCRX
Q4 25
$32.0M
$123.1M
Q3 25
$8.3M
$144.0M
Q2 25
$9.8M
$176.7M
Q1 25
$12.9M
$210.2M
Q4 24
$12.3M
Q3 24
$15.6M
$229.1M
Q2 24
$1.6M
Q1 24
$1.4M
Total Assets
MSAI
MSAI
TCRX
TCRX
Q4 25
$35.5M
$228.8M
Q3 25
$11.9M
$262.2M
Q2 25
$14.6M
$298.6M
Q1 25
$16.4M
$332.7M
Q4 24
$15.5M
Q3 24
$18.9M
$348.0M
Q2 24
$16.4M
Q1 24
$14.1M
Debt / Equity
MSAI
MSAI
TCRX
TCRX
Q4 25
0.26×
Q3 25
0.23×
Q2 25
0.18×
Q1 25
0.15×
Q4 24
Q3 24
0.13×
Q2 24
0.41×
Q1 24
2.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSAI
MSAI
TCRX
TCRX
Operating Cash FlowLast quarter
$-2.2M
$-32.0M
Free Cash FlowOCF − Capex
$-2.6M
$-32.2M
FCF MarginFCF / Revenue
-187.3%
-1253.3%
Capex IntensityCapex / Revenue
26.2%
6.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.7M
$-139.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSAI
MSAI
TCRX
TCRX
Q4 25
$-2.2M
$-32.0M
Q3 25
$-1.8M
$-32.5M
Q2 25
$-804.0K
$-33.3M
Q1 25
$-3.2M
$-37.6M
Q4 24
$-3.1M
Q3 24
$-12.7M
$-27.9M
Q2 24
$-303.0K
Q1 24
$492.0K
Free Cash Flow
MSAI
MSAI
TCRX
TCRX
Q4 25
$-2.6M
$-32.2M
Q3 25
$-2.1M
$-33.9M
Q2 25
$-1.3M
$-34.5M
Q1 25
$-3.6M
$-39.1M
Q4 24
$-4.1M
Q3 24
$-13.2M
$-29.3M
Q2 24
$-844.0K
Q1 24
$-79.0K
FCF Margin
MSAI
MSAI
TCRX
TCRX
Q4 25
-187.3%
-1253.3%
Q3 25
-136.1%
-1349.6%
Q2 25
-91.5%
-1123.1%
Q1 25
-308.6%
-1801.8%
Q4 24
-294.6%
Q3 24
-823.2%
-2792.0%
Q2 24
-39.7%
Q1 24
-3.5%
Capex Intensity
MSAI
MSAI
TCRX
TCRX
Q4 25
26.2%
6.7%
Q3 25
21.5%
56.8%
Q2 25
34.8%
41.6%
Q1 25
37.2%
70.6%
Q4 24
76.2%
Q3 24
30.5%
130.6%
Q2 24
25.5%
Q1 24
25.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons